Advertisement
Research Article| Volume 14, ISSUE 2, P309-327, April 01, 1998

ANTIBIOTIC RESISTANCE

Control Strategies
  • Author Footnotes
    * From the Infectious Disease Division, Winthrop-University Hospital, Mineola; and the State University of New York School of Medicine, Stony Brook, New York
    Burke A. Cunha
    Footnotes
    * From the Infectious Disease Division, Winthrop-University Hospital, Mineola; and the State University of New York School of Medicine, Stony Brook, New York
    Search for articles by this author
  • Author Footnotes
    * From the Infectious Disease Division, Winthrop-University Hospital, Mineola; and the State University of New York School of Medicine, Stony Brook, New York
      The medical literature contains numerous articles concerned with antibiotic resistance. Many describe the mechanisms of resistance, but to noninfectious disease clinicians terminology is variable and often confusing. The resistance described is relative rather than absolute, and usually refers to acquired rather than natural resistance. Relative resistance refers to the gradual increase in the minimal inhibitory concentration (MIC90) that occurs in susceptible organisms over time. In relative resistance an antibiotic is still effective against the sensitive organism. Increase in relative resistance is manifested by a gradual increase in MICs, and accounts for most of the resistance problems referred to in the literature and encountered in clinical practice. Absolute resistance occurs when a previously sensitive organism suddenly is no longer sensitive to an antibiotic, independent of the dose. Acquired absolute resistance to antibiotic therapy represents the most common and serious resistance problem encountered in critical care practice.

      Cunha BA: Emerging resistant organisms in the outpatient setting. Semin Respir Ther (in press), 1997.

      • Danziger L.H.
      • Pendland S.L.
      Bacterial resistance to β-lactam antibiotics.
      • Dudley M.
      Bacterial resistance mechanisms to β-lactam antibiotics: assessment of management strategies.
      • Marr J.J.
      • Moffitt H.L.
      • Kunin C.M.
      Guidelines for improving the use of antimicrobial agents in hospitals: a statement by the Infectious Disease Society of America.
      • Murray B.E.
      Problems and dilemmas of antimicrobial resistance.
      • O'Brien T.F.
      The global epidemic nature of antimicrobial resistance and the need to monitor and manage it locally.
      • Qadri S.M.H.
      • Kroschinsky R.
      • Cunha B.A.
      Antimicrobial resistance of clinical isolates in Saudi Arabia and the USA.
      • Qadri S.M.H.
      • Cunha B.A.
      • Domenico P.
      Activity of cefepime against nosocomial bacteremia blood culture isolates.
      • Qadri S.M.H.
      • Ueno Y.
      • Cunha B.A.
      Susceptibility of clinical isolates to expanded spectrum β-lactams alone and in the presence of β-lactamase inhibitors.
      • Shea K.W.
      • Ueno Y.
      • Abumustafa F.
      • et al.
      Doxycycline activity against Streptococcus pneumoniae..
      • Tenover F.C.
      • McGowan Jr, J.E.
      Reasons for the emergence of antibiotic resistance.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Critical Care Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Absalon J.
        • Domenico P.
        • Ortega A.M.
        • et al.
        The antibacterial activity of ofloxacin versus ciprofloxacin against Pseudomonas aeruginosa in human urine.
        Adv Ther. 1996; 13: 191
        • Anonymous
        Panel designs model strategic plan for tackling in-hospital antimicrobial resistance.
        Am J Health Syst Pharm. 1996; 53: 603
        • Briceland L.L.
        • Nightingale C.H.
        • Quintiliani R.
        • et al.
        Antibiotic streamlining from combination therapy to monotherapy using an interdisciplinary approach.
        Arch Intern Med. 1988; 148: 2019
        • Cunha B.A.
        Aminoglycosides—Current perspectives.
        Pharmacotherapy. 1988; 8: 334
        • Cunha B.A.
        The aminopenicillins.
        Urology. 1992; 40: 186
        • Cunha B.A.
        Third-generation cephalosporins: a review.
        Clin Ther. 1992; 14: 616
        • Cunha B.A.
        Intensive care, not intensive antibiotics.
        Heart Lung. 1994; 23: 361
        • Cunha B.A.
        • Klein N.C.
        The selection and use of cephalosporins: a review.
        Adv Ther. 1995; 12: 83
        • Cunha B.A.
        Antibiotic treatment of sepsis.
        Med Clin North Am. 1995; 79: 551
        • Cunha B.A.
        Antibiotic intravenous to oral switch therapy.
        Postgrad Med. 1997; 100: 111
        • Cunha B.A.
        New uses of older antibiotics.
        Postgrad Med. 1997; 100: 68
        • Cunha B.A.
        The significance of antibiotic false sensitivity testing with in vitro testing.
        J Chemother. 1997; 9: 25
      1. Cunha BA: Emerging resistant organisms in the outpatient setting. Semin Respir Ther (in press), 1997.

        • Danziger L.H.
        • Pendland S.L.
        Bacterial resistance to β-lactam antibiotics.
        Am J Hosp Pharm. 1995; 52: S3
        • Dudley M.
        Bacterial resistance mechanisms to β-lactam antibiotics: assessment of management strategies.
        Pharmacotherapy. 1995; 15: 9S
        • Dunagan W.C.
        • Medoff G.
        Formulary control of antimicrobial usage.
        What price freedom? Diagn Microbiol Infect Dis. 1993; 16: 265
        • Fraimow H.S.
        • Abrutyn E.
        Pathogens resistant to antimicrobial agents.
        Infect Dis Clin North Am. 1995; 9: 497-529
        • Goldmann D.A.
        • Huskins W.C.
        Control of nosocomial antimicrobial-resistant bacteria: A strategic priority for hospitals worldwide.
        Clin Infect Dis. 1997; 24: S139
        • Goldmann D.A.
        • Weinstein R.A.
        • Wenzel R.P.
        • et al.
        Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals. A challenge to hospital leadership.
        JAMA. 1996; 275: 234
        • Hedge D.D.
        Antimicrobial resistance: controlling the problem.
        S Dakota J Med. 1995; 48: 197
        • Hughes J.M.
        • Tenover F.C.
        Approaches to limiting emergence of antimicrobial resistance in bacteria in human populations.
        Clin Infect Dis. 1997; 24: S131
        • Klem C.
        • Dasta J.F.
        Efforts of pharmacy to reduce antibiotic resistance.
        New Horiz. 1996; 4: 377
        • Marr J.J.
        • Moffitt H.L.
        • Kunin C.M.
        Guidelines for improving the use of antimicrobial agents in hospitals: a statement by the Infectious Disease Society of America.
        J Infect Dis. 1988; 157: 869
        • McGowan Jr, J.E.
        Is antimicrobial resistance in hospital microorganisms related to antibiotic use?.
        Bull NY Acad Med. 1987; 63: 253
        • McGowan Jr, J.E.
        Minimizing antimicrobial resistance in hospital bacteria: Can switching or cycling drugs help?.
        Infect Control. 1986; 7: 573
        • McGowan Jr, J.E.
        • Gerding D.N.
        Does antibiotic restriction prevent resistance?.
        New Horiz. 1996; 4: 370
        • Murray B.E.
        Problems and dilemmas of antimicrobial resistance.
        Pharmacotherapy. 1992; 12: 86S
        • O'Brien T.F.
        The global epidemic nature of antimicrobial resistance and the need to monitor and manage it locally.
        Clin Infect Dis. 1997; 24: S2
        • Qadri S.M.H.
        • Kroschinsky R.
        • Cunha B.A.
        Antimicrobial resistance of clinical isolates in Saudi Arabia and the USA.
        Curr Ther Res. 1990; 47: 130
        • Qadri S.M.H.
        • Cunha B.A.
        • Domenico P.
        Activity of cefepime against nosocomial bacteremia blood culture isolates.
        J Antimicrob Chemother. 1995; 36: 531
        • Qadri S.M.H.
        • Ueno Y.
        • Cunha B.A.
        Susceptibility of clinical isolates to expanded spectrum β-lactams alone and in the presence of β-lactamase inhibitors.
        Chemotherapy. 1996; 42: 334
        • Quintiliani R.
        • Klimek J.J.
        • Nightingale C.H.
        Restriction policies for therapy with combination antibiotics.
        J Infect Dis. 1986; 153: 645
        • Quintiliani R.
        • Nicolau D.P.
        • Nightingale C.H.
        Clinical relevance of penicillin-resistant Streptococcus pneumoniae, with particular attention to therapy with ceftizoxime, cefotaxime, and ceftriaxone.
        Infect Dis Clin Pract. 1996; 5: S37
        • Schentag J.J.
        Understanding and managing microbial resistance in institutional settings.
        Am J Health-Syst Pharm. 1997; 52: S9
        • Segal-Maurer S.
        • Urban C.
        • Rahal Jr, J.J.
        Current perspectives on multidrug-resistant bacteria. Epidemiology and control.
        Infect Dis Clin North Am. 1996; 10: 939
        • Shea K.W.
        • Ueno Y.
        • Abumustafa F.
        • et al.
        Doxycycline activity against Streptococcus pneumoniae..
        Chest. 1995; 107: 1775
        • Stelling J.M.
        • O'Brien T.F.
        Surveillance of antimicrobial resistance: the WHONET program.
        Clin Infect Dis. 1997; 24: S157
        • Strausbaugh L.
        Antimicrobial resistance: Problems, laments, and hopes.
        Am J Infect Control. 1997; 25: 294
        • Stratton IV, C.W.
        • Ratner H.
        • Johnston P.E.
        • et al.
        Focused microbiologic surveillance by specific hospital unit: Practical application and clinical utility.
        Clin Ther. 1993; 15: 12
        • Tenover F.C.
        • McGowan Jr, J.E.
        Reasons for the emergence of antibiotic resistance.
        Am J Med Sci. 1996; 311: 9